The novel treatment of tirzepatide peptide represents a significant development in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets dual pathways – GLP-1 and GIP – resulting in https://tirzepatide-peptide227258.qowap.com/101073322/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment